Blood Advances (Aug 2017)

Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946.

Journal volume & issue
Vol. 1, no. 19
p. 1537

Abstract

Read online

No abstracts available.